TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 NOK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 982,868 | 992,037 | 948,332 |
Earnings before taxes | 29,919 | 23,800 | 39,013 |
Total assets | 475,417 | 534,914 | 464,438 |
Current assets | 475,122 | 490,491 | 419,916 |
Current liabilities | 278,969 | 335,098 | 251,789 |
Equity capital | 192,443 | 179,840 | 211,171 |
- share capital | 5,365 | 5,654 | 5,281 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 40.5% | 33.6% | 45.5% |
Turnover per employee | 6,552 | 6,614 | 6,322 |
Profit as a percentage of turnover | 3.0% | 2.4% | 4.1% |
Return on assets (ROA) | |||
Current ratio | 170.3% | 146.4% | 166.8% |
Return on equity (ROE) | 15.5% | 13.2% | 18.5% |
Change turnover | 41,553 | -23,162 | -118,723 |
Change turnover % | 4% | -2% | -11% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.